Home Biosimilar Antibodies Angiogenesis FGFR Bemarituzumab (Anti-FGFR2 / CD332) For research use only.
Not for use in humans.

Bemarituzumab (Anti-FGFR2 / CD332)

Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.

Bemarituzumab (Anti-FGFR2 / CD332)

Click to purchase the isotype control of Bemarituzumab (Anti-FGFR2 / CD332)

1 Customer Review

Purity & Quality Control

Batch: A249701 Purity: 99% Protein concentration: 3.55mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective FGFR Inhibitors

Biological Activity

Description Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.

Product Details

CAS No. 1952272-74-0
Molecular Weight 145.24 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Bemarituzumab (Anti-FGFR2 / CD332) | Bemarituzumab (Anti-FGFR2 / CD332) supplier | purchase Bemarituzumab (Anti-FGFR2 / CD332) | Bemarituzumab (Anti-FGFR2 / CD332) cost | Bemarituzumab (Anti-FGFR2 / CD332) manufacturer | order Bemarituzumab (Anti-FGFR2 / CD332) | Bemarituzumab (Anti-FGFR2 / CD332) distributor